HDAC-IN-52_product_DataBase

Bioactivity	HDAC-IN-52 is a pyridine-containing HDAC inhibitor, with IC50s of 0.189, 0.227, 0.440 and 0.446 μM for HDAC1, HDAC2, HDAC3, and HDAC10, respectively. HDAC-IN-52 can be used for the research of cancer[1].
Invitro	HDAC-IN-52 (compound 8f) (72 hours) 抑制 HCT116，A549 和 K562 细胞的增殖，IC50 值分别为 0.43，1.28 和 0.37 μM[1 ]。HDAC-IN-52 (1-5 μM; 24-48 h) 在 48 小时后显着诱导白血病 U937 细胞死亡，G1 前期阻滞分别为 76% 和 100%[1]。HDAC-IN-52 (1-5 μM; 48 h) 增加 p21，BAX 和 BAK 的 mRNA 表达，下调细胞周期蛋白 D1 和 BCL-2[1]。
Name	HDAC-IN-52
CAS	2075787-77-6
Formula	C24H20N4O2
Molar Mass	396.44
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Bello ED, et, al. Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells. Eur J Med Chem. 2022 Dec 15;247:115022.

PeptideDB